BlueOakNx joins the WMS 2026 Congress as Sponsor

BlueOakNx is a Public Benefit Corporation on a mission to provide access to science-based, practitioner-grade nutraceuticals that enable a better quality of life from the inside out. The first product Mitokatylst™ - E is backed by 15 preclinical and clinical studies and 64 peer-reviewed papers. Mitokatlyst™ is the first targeted molecule clinically proven to induce mitochondrial biogenesis and boost cellular energy. This promotes skeletal muscle strength, supports metabolic function, supports cardiovascular health, and stimulates a healthy inflammatory response. As of September of 2024, 14 more clinical trials and observational studies have been independently initiated at various universities in the US, Scotland, and Sweden. Co-founder Sundeep Dugar, PhD, also leads the $101M XPrize Healthspan Semifinalist team, A New Dimension.

 

Learn more at www.blueoaknx.com